Autopsy report · NCT05410041

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“No participants.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Beijing Boren Hospital
Sponsor type: University, hospital or other
Conditions: Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Non Hodgkin Lymphoma
Interventions: CAR-NK-CD19 Cells
Participants: 0
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.